| Product Code: ETC7602914 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Bacteriophages Therapy Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Iraq Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Iraq Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Iraq Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Iraq Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Iraq Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iraq Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Iraq |
4.2.2 Growing awareness about the effectiveness of bacteriophages therapy |
4.2.3 Supportive government initiatives promoting research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 Limited research and development infrastructure in Iraq |
4.3.2 Lack of skilled professionals in bacteriophages therapy |
4.3.3 Regulatory challenges and approval processes for bacteriophages therapy products in Iraq |
5 Iraq Bacteriophages Therapy Market Trends |
6 Iraq Bacteriophages Therapy Market, By Types |
6.1 Iraq Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Iraq Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Iraq Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Iraq Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Iraq Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Iraq Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Iraq Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Iraq Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Iraq Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Iraq Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Iraq Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Iraq Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Iraq Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Iraq Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Iraq Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Iraq Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Iraq Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Iraq Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Iraq Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Iraq Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Iraq Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Iraq Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Iraq Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Iraq Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Iraq Bacteriophages Therapy Market Export to Major Countries |
7.2 Iraq Bacteriophages Therapy Market Imports from Major Countries |
8 Iraq Bacteriophages Therapy Market Key Performance Indicators |
8.1 Clinical trial success rates for bacteriophages therapy in Iraq |
8.2 Number of research publications on bacteriophages therapy from Iraqi institutions |
8.3 Funding allocated by the government towards bacteriophages therapy research and development in Iraq |
9 Iraq Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Iraq Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Iraq Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Iraq Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Iraq Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iraq Bacteriophages Therapy Market - Competitive Landscape |
10.1 Iraq Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Iraq Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here